Alex Tsodikov

University of Michigan — United States

Medicine · Health Sciences

34h-index5.5kcitations83works9.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(21), Prostate Cancer Treatment and Research(19), Global Cancer Incidence and Screening(13), Statistical Methods and Inference(11), Musculoskeletal pain and rehabilitation(10)

Publications82 total

Mortality reduction and cumulative excess incidence (CEI) in the prostate-specific antigen (PSA) screening era
Scientific Reports·2024· 9 citedOpen Access
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and <scp>InternatiOnal</scp> Networking Clinical Database and Repository
Arthritis & Rheumatology·2023· 37 citedOpen Access
Decreased Left Atrial Reservoir Strain Is Associated with Adverse Outcomes in Restrictive Cardiomyopathy
Journal of Clinical Medicine·2022· 9 citedOpen Access
Evaluation of Prostate Cancer Screening Strategies in a Low-Resource, High-risk Population in the Bahamas
JAMA Health Forum·2022· 9 citedOpen Access
Patient Self-Management of Benign Paroxysmal Positional Vertigo: Instructional Video Development and Preliminary Evaluation of Behavioral Outcomes.
PubMed·2022· 1 cited
Incidence and predictors of persistent pelvic pain following hysterectomy in women with chronic pelvic pain
American Journal of Obstetrics and Gynecology·2021· 73 citedOpen Access
Detection of prognostic cancer-specific circular RNA in plasma.
Journal of Clinical Oncology·2021
The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based Analysis
JNCI Journal of the National Cancer Institute·2021· 46 citedOpen Access
Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer
JNCI Cancer Spectrum·2020· 18 citedOpen Access
Joint modeling and multiple comparisons with the best of data from a SMART with survival outcomes
Biostatistics·2020· 3 citedOpen Access
Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer
JNCI Journal of the National Cancer Institute·2020· 33 citedOpen Access
Likelihood Transformations and Artificial Mixtures
2020· 1 cited
Analysis of mammographic density as a predictor for breast cancer occurrence
2019
3266 Understanding epicardial adipose biology by imaging, transcriptomic, and lipidomic profiling
Journal of Clinical and Translational Science·2019Open Access
Clinical Predictors and Disparities in Surveillance PSA Utilization after Prostate Cancer Treatment
International Journal of Radiation Oncology*Biology*Physics·2018Open Access
Adjusted Citation Rate, an Alternative Metric to Measure the Impact of General Radiology Journals
Academic Radiology·2018· 1 cited
Water–fat magnetic resonance imaging quantifies relative proportions of brown and white adipose tissues: ex-vivo experiments
Journal of Medical Imaging·2018· 3 citedOpen Access
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
Annals of Internal Medicine·2018· 43 cited
The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials
Cancer·2017· 66 citedOpen Access
Opioid Prescribing Patterns, Patient Use, and Postoperative Pain After Hysterectomy for Benign Indications
Obstetrics and Gynecology·2017· 136 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Ruth Etzioni(14), Roman Gulati(13), Angela B. Mariotto(10), Eveline A.M. Heijnsdijk(9), Harry J. de Koning(7), Chad M. Brummett(7), Eric J. Feuer(5), Daniel J. Clauw(5), Scott A. Tomlins(4), Arul M. Chinnaiyan(4), Andrej Yu. Yakovlev(4), Afton L. Hassett(4), Gerrit Draisma(3), David F. Penson(3), Rohit Mehra(3), Tiago M. de Carvalho(3), Elisabeth M. Wever(3), Jeffrey Katcher(3), Sawsan As‐Sanie(3), Rajat Banerjee(3)